Skip to main content

Peer Review reports

From: Evaluating in vivo effectiveness of sotrovimab for the treatment of Omicron subvariant BA.2 versus BA.1: a multicentre, retrospective cohort study

Original Submission
20 Aug 2023 Submitted Original manuscript
5 Oct 2023 Reviewed Reviewer Report
7 Oct 2023 Reviewed Reviewer Report
13 Dec 2023 Author responded Author comments - Carson K.L. Lo
Resubmission - Version 2
13 Dec 2023 Submitted Manuscript version 2
15 Dec 2023 Reviewed Reviewer Report
28 Dec 2023 Reviewed Reviewer Report
14 Jan 2024 Author responded Author comments - Carson K.L. Lo
Resubmission - Version 3
14 Jan 2024 Submitted Manuscript version 3
Publishing
16 Jan 2024 Editorially accepted
24 Jan 2024 Article published 10.1186/s13104-024-06695-x

You can find further information about peer review here.

Back to article page